Stocksigma LogoStocksigma Logo

Hindustan Bio Sciences Approves Capital Reduction and Consolidation Scheme

On 31 Aug'26, the board approved a capital reduction scheme to offset accumulated losses. Paid-up capital will be reduced from Rs. 2.05 cr to Rs

Hindustan Bio Sciences Approves Capital Reduction and Consolidation Scheme

Hindustan Bio Sciences Ltd 路 Outcome 路 31 Aug 2026, 10:12 pm

Hindustan Bio Sciences Approves Capital Reduction and Consolidation Scheme On 31 Aug'26, the board approved a capital reduction scheme to offset accumulated losses. Paid-up capital will be reduced from Rs. 2.05 cr to Rs. 92.26 lakh by cancelling 56.38 lakh equity shares. This will set off Rs. 1.13 cr against accumulated losses of Rs. 1.22 cr. Subsequently, the remaining shares (face value Rs. 2) will be consolidated into new shares of Rs. 10 face value. Shareholders will receive 9 new shares (Rs. 10 FV) for every 100 old shares (Rs. 2 FV). The scheme requires shareholder and NCLT approval.

Original exchange filing (PDF)

More announcements from Hindustan Bio Sciences Ltd

All Hindustan Bio Sciences Ltd announcements